Yttrium 90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy for B-Cell Non-Hodgkin's Lymphoma: Letter from the Editors

Leonard M. Freeman, M. Donald Blaufox

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1
Number of pages	1
Journal	Seminars in nuclear medicine
Volume	34
Issue number	1 SUPPL.1
DOIs	https://doi.org/10.1053/j.semnuclmed.2003.11.006
State	Published - Jan 2004
Externally published	Yes

ASJC Scopus subject areas

@article{e2f4857d652b4d6f8b900508da2606f5,

title = "Yttrium 90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy for B-Cell Non-Hodgkin's Lymphoma: Letter from the Editors",

author = "Freeman, {Leonard M.} and Blaufox, {M. Donald}",

year = "2004",

month = jan,

doi = "10.1053/j.semnuclmed.2003.11.006",

language = "English (US)",

volume = "34",

pages = "1",

journal = "Seminars in nuclear medicine",

issn = "0001-2998",

publisher = "W.B. Saunders Ltd",

number = "1 SUPPL.1",

}

TY - JOUR

T1 - Yttrium 90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy for B-Cell Non-Hodgkin's Lymphoma

T2 - Letter from the Editors

AU - Freeman, Leonard M.

AU - Blaufox, M. Donald

PY - 2004/1

Y1 - 2004/1

UR - http://www.scopus.com/inward/record.url?scp=0842324897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842324897&partnerID=8YFLogxK

U2 - 10.1053/j.semnuclmed.2003.11.006

DO - 10.1053/j.semnuclmed.2003.11.006

M3 - Editorial

AN - SCOPUS:0842324897

SN - 0001-2998

VL - 34

SP - 1

JO - Seminars in nuclear medicine

JF - Seminars in nuclear medicine

IS - 1 SUPPL.1

ER -